Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 4 | 4 | PSYCHIATRY//PSYCHOLOGY, CLINICAL//PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | 1867560 |
| 77 | 3 | HIV//AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV//CONTRACEPTION | 85713 |
| 24 | 2 | HIV//AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV//HIV AIDS | 35880 |
| 29484 | 1 | SET POINT VIRAL LOAD//BETWEEN HOST EVOLUTION//HIV TRANSMISSION GROUP | 203 |
Terms with highest relevance score |
| rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|---|
| 1 | SET POINT VIRAL LOAD | authKW | 798455 | 3% | 86% | 6 |
| 2 | BETWEEN HOST EVOLUTION | authKW | 310511 | 1% | 100% | 2 |
| 3 | HIV TRANSMISSION GROUP | authKW | 310511 | 1% | 100% | 2 |
| 4 | VIRUS INDUCED TARGET CELL ACTIVATION | authKW | 310511 | 1% | 100% | 2 |
| 5 | ABSOLUTE CD4 CELL COUNT | authKW | 155256 | 0% | 100% | 1 |
| 6 | ANATOMIC COMPARTMENTS | authKW | 155256 | 0% | 100% | 1 |
| 7 | ANTIRETROVIRAL THERAPY CHANGE | authKW | 155256 | 0% | 100% | 1 |
| 8 | ANTIRETROVIRAL THERAPY DISCONTINUATION | authKW | 155256 | 0% | 100% | 1 |
| 9 | ANTIRETROVIRAL TREATMENT OUTCOMES | authKW | 155256 | 0% | 100% | 1 |
| 10 | BETWEEN HOST MODELLING | authKW | 155256 | 0% | 100% | 1 |
Web of Science journal categories |
| chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | Infectious Diseases | 8977 | 62% | 0% | 126 |
| 2 | Virology | 2293 | 26% | 0% | 52 |
| 3 | Immunology | 1555 | 42% | 0% | 85 |
| 4 | Microbiology | 288 | 17% | 0% | 34 |
| 5 | Women’s Studies | 253 | 3% | 0% | 7 |
| 6 | Public, Environmental & Occupational Health | 164 | 13% | 0% | 26 |
| 7 | Pharmacology & Pharmacy | 59 | 12% | 0% | 25 |
| 8 | Medicine, General & Internal | 44 | 8% | 0% | 17 |
| 9 | Parasitiology | 38 | 3% | 0% | 6 |
| 10 | Obstetrics & Gynecology | 22 | 4% | 0% | 8 |
Address terms |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | CIDAG | 155256 | 0% | 100% | 1 |
| 2 | CONSELLERIA SANIDAD COMUNIDAD VALENCIANA | 155256 | 0% | 100% | 1 |
| 3 | FONDAT MERIEUXCNRSINSERMU1111UMR5308 | 155256 | 0% | 100% | 1 |
| 4 | HIV NETHERLANDS AUSTRALIA THAILAND HIVNAT | 155256 | 0% | 100% | 1 |
| 5 | HOP NECKER ENFANTS MALADSERV VIROL | 155256 | 0% | 100% | 1 |
| 6 | HOST PATHOGEN GENOM GRP | 155256 | 0% | 100% | 1 |
| 7 | IFRICI | 155256 | 0% | 100% | 1 |
| 8 | IMMUNOVIROL POLE | 155256 | 0% | 100% | 1 |
| 9 | INEDPARIS 10SERV EPIDEMIOL SANTE PUBL | 155256 | 0% | 100% | 1 |
| 10 | INSERMHIV EPIDEMIOL | 155256 | 0% | 100% | 1 |
Journals |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | HIV CLINICAL TRIALS | 14477 | 3% | 1% | 7 |
| 2 | HIV MEDICINE | 10965 | 4% | 1% | 9 |
| 3 | LANCET HIV | 9975 | 1% | 2% | 3 |
| 4 | AIDS | 7068 | 10% | 0% | 20 |
| 5 | ANTIVIRAL THERAPY | 6505 | 4% | 0% | 9 |
| 6 | JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES | 5465 | 4% | 0% | 8 |
| 7 | JOURNAL OF THE INTERNATIONAL AIDS SOCIETY | 3521 | 2% | 1% | 4 |
| 8 | JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES | 2800 | 4% | 0% | 9 |
| 9 | EPIDEMICS | 2594 | 1% | 1% | 2 |
| 10 | GENDER MEDICINE | 2254 | 1% | 1% | 2 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |